Delta Asset Management’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-112
| Closed | -$18.9K | – | 607 |
|
|
2025
Q4 | $18.9K | Hold |
112
| – | – | ﹤0.01% | 383 |
|
|
2025
Q3 | $16.2K | Hold |
112
| – | – | ﹤0.01% | 390 |
|
|
2025
Q2 | $14.2K | Hold |
112
| – | – | ﹤0.01% | 403 |
|
|
2025
Q1 | $14.3K | Hold |
112
| – | – | ﹤0.01% | 394 |
|
|
2024
Q4 | $14.8K | Hold |
112
| – | – | ﹤0.01% | 400 |
|
|
2024
Q3 | $16.3K | Hold |
112
| – | – | ﹤0.01% | 389 |
|
|
2024
Q2 | $15.4K | Hold |
112
| – | – | ﹤0.01% | 388 |
|
|
2024
Q1 | $15.4K | Hold |
112
| – | – | ﹤0.01% | 399 |
|
|
2023
Q4 | $15.2K | Hold |
112
| – | – | ﹤0.01% | 401 |
|
|
2023
Q3 | $13.7K | Hold |
112
| – | – | ﹤0.01% | 406 |
|
|
2023
Q2 | $14.2K | Hold |
112
| – | – | ﹤0.01% | 412 |
|
|
2023
Q1 | $14.5K | Hold |
112
| – | – | ﹤0.01% | 384 |
|
|
2022
Q4 | $14.7K | Buy |
+112
| New | +$14.5K | ﹤0.01% | 378 |
|
|
2022
Q1 | – | Sell |
-112
| Closed | -$17K | – | 336 |
|
|
2021
Q4 | $17K | Hold |
112
| – | – | ﹤0.01% | 378 |
|
|
2021
Q3 | $18K | Hold |
112
| – | – | ﹤0.01% | 363 |
|
|
2021
Q2 | $18K | Hold |
112
| – | – | ﹤0.01% | 370 |
|
|
2021
Q1 | $17K | Hold |
112
| – | – | ﹤0.01% | 360 |
|
|
2020
Q4 | $17K | Hold |
112
| – | – | ﹤0.01% | 352 |
|
|
2020
Q3 | $15K | Buy |
112
+10
| +10% | +$1.36K | ﹤0.01% | 352 |
|
|
2020
Q2 | $14K | Hold |
102
| – | – | ﹤0.01% | 361 |
|
|
2020
Q1 | $11K | Hold |
102
| – | – | ﹤0.01% | 379 |
|
|
2019
Q4 | $12K | Hold |
102
| – | – | ﹤0.01% | 416 |
|
|
2019
Q3 | $10K | Hold |
102
| – | – | ﹤0.01% | 428 |
|
|
2019
Q2 | $11K | Hold |
102
| – | – | ﹤0.01% | 381 |
|
|
2019
Q1 | $11K | Hold |
102
| – | – | ﹤0.01% | 364 |
|
|
2018
Q4 | $10K | Hold |
102
| – | – | ﹤0.01% | 421 |
|
|
2018
Q3 | $12K | Hold |
102
| – | – | ﹤0.01% | 433 |
|
|
2018
Q2 | $11K | Hold |
102
| – | – | ﹤0.01% | 433 |
|
|
2018
Q1 | $11K | Hold |
102
| – | – | ﹤0.01% | 431 |
|
|
2017
Q4 | $11K | Hold |
102
| – | – | ﹤0.01% | 424 |
|
|
2017
Q3 | $11K | Hold |
102
| – | – | ﹤0.01% | 398 |
|
|
2017
Q2 | $11K | Hold |
102
| – | – | ﹤0.01% | 398 |
|
|
2017
Q1 | $10K | Hold |
102
| – | – | ﹤0.01% | 416 |
|
|
2016
Q4 | $9K | Hold |
102
| – | – | ﹤0.01% | 424 |
|
|
2016
Q3 | $10K | Buy |
+102
| New | +$9.7K | ﹤0.01% | 408 |
|
Other funds holding IBB
CB
Delta Asset Management's IBB Position: Q1 2026 in Review
Delta Asset Management sold out of iShares Biotechnology ETF (IBB) in Q1 2026, closing a stake of 112 shares — an estimated $18.9K sold.
Delta Asset Management first reported a position in IBB in Q3 2016 and held it in 35 quarters. The position peaked at $18.9K in Q4 2025. 921 funds tracked by Wall St. Rank hold IBB as of Q1 2026.
- Delta Asset Management reported no remaining iShares Biotechnology ETF position as of Q1 2026 after selling out during the quarter.
- Delta Asset Management sold 112 iShares Biotechnology ETF shares in Q1 2026, an estimated $18.9K.
- Delta Asset Management first reported a position in iShares Biotechnology ETF in Q3 2016 and held it in 35 quarters.
- Delta Asset Management's iShares Biotechnology ETF position peaked at $18.9K in Q4 2025.
- 921 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.
Based on Delta Asset Management's 13F filing for Q1 2026, filed 11 May 2026.